Join Michelle Martin on her tour of markets! Today's discussion covers Eli Lilly's latest drug study results and competition with Novo Nordisk. Learn about JD.com's share price drop, Johnson & Johnson's acquisition, and Lowe's revised outlook. SATS’ return to profitability and StarHub's recent broadband outage are also on the agenda. Plus, discover insights into gold's record highs and China's growing nuclear power investments with Michelle and IG Markets Yeap Jun Rong.

Market View: Lululemon Plunges, S-REITs vs Banks, Nvidia’s $13B AI Bet & Why the Dutch Are Moving Gold
12:46

Advanced Diagnostic Tests the Super Health-Conscious are opting for
25:39

Money and Me: BTO Ceiling at $16K, More Homes Coming: Is Singapore Turning Into a Buyer’s Market?
21:32